TROPONIN T, TROPONIN I NEED FURTHER STUDY TO CLARIFY THE MOST EFFECTIVE USE OF CARDIAC MARKER TESTS, PHYSICIAN SAYS IN NEJM EDITORIAL
This article was originally published in The Gray Sheet
Executive Summary
Additional studies are needed to establish the optimal usefulness of tests for troponin T and troponin I serum cardiac markers in the assessment of mortality risk from acute coronary syndromes, according to Frans Van De Werf, MD, University Hospital Gasthuisberg, Leuven, Belgium, writing in the Oct. 31 issue of the New England Journal of Medicine.